- Home
- OCGN vs CCRD Comparison
OCGN vs CCRD Comparison
Compare OCGN & CCRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCGN
- CCRD
- Stock Information
- Founded
- OCGN 2013
- CCRD 1973
- Country
- OCGN United States
- CCRD United States
- Employees
- OCGN N/A
- CCRD N/A
- Industry
- OCGN Biotechnology: Biological Products (No Diagnostic Substances)
- CCRD
- Sector
- OCGN Health Care
- CCRD
- Exchange
- OCGN Nasdaq
- CCRD Nasdaq
- Market Cap
- OCGN 189.6M
- CCRD 192.4M
- IPO Year
- OCGN N/A
- CCRD N/A
- Fundamental
- Price
- OCGN $0.70
- CCRD $18.37
- Analyst Decision
- OCGN Strong Buy
- CCRD Hold
- Analyst Count
- OCGN 3
- CCRD 1
- Target Price
- OCGN $6.33
- CCRD $21.00
- AVG Volume (30 Days)
- OCGN 4.2M
- CCRD 20.7K
- Earning Date
- OCGN 03-05-2025
- CCRD 05-01-2025
- Dividend Yield
- OCGN N/A
- CCRD N/A
- EPS Growth
- OCGN N/A
- CCRD 67.50
- EPS
- OCGN N/A
- CCRD 0.67
- Revenue
- OCGN $4,054,999.00
- CCRD $57,399,000.00
- Revenue This Year
- OCGN N/A
- CCRD $9.82
- Revenue Next Year
- OCGN N/A
- CCRD N/A
- P/E Ratio
- OCGN N/A
- CCRD $27.85
- Revenue Growth
- OCGN N/A
- CCRD 2.49
- 52 Week Low
- OCGN $0.52
- CCRD $10.09
- 52 Week High
- OCGN $2.08
- CCRD $24.97
- Technical
- Relative Strength Index (RSI)
- OCGN 53.03
- CCRD 39.07
- Support Level
- OCGN $0.69
- CCRD $19.40
- Resistance Level
- OCGN $0.80
- CCRD $21.44
- Average True Range (ATR)
- OCGN 0.05
- CCRD 0.82
- MACD
- OCGN 0.02
- CCRD -0.03
- Stochastic Oscillator
- OCGN 58.35
- CCRD 38.29
About OCGN Ocugen Inc.
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").
About CCRD CoreCard Corporation
CoreCard Corp is engaged in the business of providing technology solutions and processing services to the financial technology and services market. It designs, develops and markets a comprehensive suite of software solutions to program managers, accounts receivable businesses, financial institutions, retailers and processors to manage their credit and debit cards, prepaid cards, private label cards, fleet cards, buy now pay later programs, loyalty programs and accounts receivable and loan transactions. The CoreCard software platform and modules include CoreENGINE, CoreISSUE, CoreFRAUD, CoreCOLLECT, CoreAPP, CoreMONEY and CoreACQUIRE. Its customers are located in the U.S, European Union and the Middle East of which key revenue is derived from the U.S.